Statistics for Aileron Therapeutics (id:6267 ALRN)
Valuation metrics
Market cap
53.51M
Enterprise value
85.27M
Trailing P/E (ttm)
-0.72
Forward P/E
-1.39
PEG ratio
-1.39
Price/Sales (ttm)
Price/Book (mrq)
1.75
Enterprise Value/Revenue
Enterprise Value/EBITDA
-3.36
Overview
Shares outstanding
21.67M
Float
19.42M
Shares short
233.27K
% Held by insiders
0.01%
% Held by institutions
0.28%
Average volume (10 days)
100.75K
Average volume (90 days)
Price summary
52-Week low
1.61
52-Week high
7.42
52-Week change
25.10%
Beta
2.34
50-Day moving average
3.48
200-Day moving average
3.75
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
November 11th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-25.86%
Return on equity
-44.32%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-25,396,000.00
Net income to common (ttm)
-25,221,000.00
Diluted EPS (ttm)
-2.88
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
21.92M
Total cash per share (mrq)
1.01
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
469.10%
Book value per share (mrq)
1.41
Cash flow
Cash flow statement
-25,691,000.00
Levered free cash flow (LFCF)
-12,065,875.00